These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 17623963

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
    Kamperis K, Rittig S, Radvanska E, Jørgensen KA, Djurhuus JC.
    J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL, Walle CV, Vansintjan P, Raes AM, De Guchtenaere AR, Van Laecke E, Hoebeke P, Vande Walle JG.
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Poor compliance with primary nocturnal enuresis therapy may contribute to insufficient desmopressin response.
    Van Herzeele C, Alova I, Evans J, Eggert P, Lottmann H, Nørgaard JP, Vande Walle J.
    J Urol; 2009 Oct; 182(4 Suppl):2045-9. PubMed ID: 19695639
    [Abstract] [Full Text] [Related]

  • 11. The Canadian Enuresis Study and Evaluation--short- and long-term safety and efficacy of an oral desmopressin preparation.
    Wolfish NM, Barkin J, Gorodzinsky F, Schwarz R.
    Scand J Urol Nephrol; 2003 Oct; 37(1):22-7. PubMed ID: 12745738
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tailoring treatment of monosymptomatic nocturnal enuresis: the role of maximum voided capacity.
    Tauris LH, Kamperis K, Hagstroem S, Bower WF, Rittig S.
    J Urol; 2012 Feb; 187(2):664-9. PubMed ID: 22177206
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of different modes of combined therapy in children with monosymptomatic nocturnal enuresis.
    Vogt M, Lehnert T, Till H, Rolle U.
    BJU Int; 2010 May; 105(10):1456-9. PubMed ID: 19764973
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prospective evaluation of factors affecting the response and relapse rates to desmopressin therapy in male monosymptomatic enuretic adults.
    Burgu B, Gökce MI, Gücük A, Soygür T.
    Urology; 2009 Oct; 74(4):915-9. PubMed ID: 19643460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.